Published in J Cell Sci on August 15, 2011
Aurora A kinase (AURKA) in normal and pathological cell division. Cell Mol Life Sci (2012) 1.84
Development of a chemical genetic approach for human aurora B kinase identifies novel substrates of the chromosomal passenger complex. Mol Cell Proteomics (2012) 0.96
Genome-wide association study identifies multiple susceptibility loci for glioma. Nat Commun (2015) 0.93
PHLDA1 expression is controlled by an estrogen receptor-NFκB-miR-181 regulatory loop and is essential for formation of ER+ mammospheres. Oncogene (2014) 0.86
Issues in interpreting the in vivo activity of Aurora-A. Expert Opin Ther Targets (2014) 0.80
Expression of PAR-4 and PHLDA1 is prognostic for overall and disease-free survival in oral squamous cell carcinomas. Virchows Arch (2013) 0.80
Modulation of ErbB2 blockade in ErbB2-positive cancers: the role of ErbB2 Mutations and PHLDA1. PLoS One (2014) 0.78
Cdk5-Foxo3 axis: initially neuroprotective, eventually neurodegenerative in Alzheimer's disease models. J Cell Sci (2016) 0.78
TDAG51 deficiency promotes oxidative stress-induced apoptosis through the generation of reactive oxygen species in mouse embryonic fibroblasts. Exp Mol Med (2013) 0.78
Correlation of decreased expression of PHLDA1 protein with malignant phenotype of gastric adenocarcinoma. Int J Clin Exp Pathol (2015) 0.77
Prognostic significance of Traf2- and Nck- interacting kinase (TNIK) in colorectal cancer. BMC Cancer (2015) 0.77
Downregulated expression of PHLDA1 protein is associated with a malignant phenotype of cholangiocarcinoma. Oncol Lett (2015) 0.76
Pleckstrin homology-like domain, family A, member 1 (PHLDA1) and cancer. Biomed Rep (2016) 0.76
Ubiquitin-Mediated Degradation of Aurora Kinases. Front Oncol (2016) 0.76
The Aurora-A-Twist1 axis promotes highly aggressive phenotypes in pancreatic carcinoma. J Cell Sci (2017) 0.75
Phosphorylation-dependent regulation of ALDH1A1 by Aurora kinase A: insights on their synergistic relationship in pancreatic cancer. BMC Biol (2017) 0.75
Cdk5-Mcl-1 axis promotes mitochondrial dysfunction and neurodegeneration in Alzheimer's disease model. J Cell Sci (2017) 0.75
American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol (2010) 14.41
Targets of the cyclin-dependent kinase Cdk1. Nature (2003) 8.05
CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis. Breast Cancer Res (2006) 6.35
Report of the AMA Council on Ethical and Judicial Affairs: professionalism in the use of social media. J Clin Ethics (2011) 5.69
"Doctor, would you prescribe a pill to help me … ?" a national survey of physicians on using medicine for human enhancement. Am J Bioeth (2011) 4.95
Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features. J Clin Oncol (2008) 4.42
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version). Arch Pathol Lab Med (2010) 4.38
A chemical-genetic strategy implicates myosin-1c in adaptation by hair cells. Cell (2002) 3.34
Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment. Breast Cancer Res Treat (2009) 2.85
American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. Arch Pathol Lab Med (2010) 2.72
A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast. J Natl Cancer Inst (2013) 2.56
A large set of Finnish affected sibling pair families with type 2 diabetes suggests susceptibility loci on chromosomes 6, 11, and 14. Diabetes (2004) 2.46
Breast cancer prognostic classification in the molecular era: the role of histological grade. Breast Cancer Res (2010) 2.33
Fast adaptation in vestibular hair cells requires myosin-1c activity. Neuron (2005) 2.11
A cellular Trojan Horse for delivery of therapeutic nanoparticles into tumors. Nano Lett (2007) 2.08
Molecular profiling assays in breast cancer: are we ready for prime time? Oncology (Williston Park) (2012) 2.04
Akt phosphorylates the Y-box binding protein 1 at Ser102 located in the cold shock domain and affects the anchorage-independent growth of breast cancer cells. Oncogene (2005) 1.89
Radiation pneumonitis in mice: a severe injury model for pneumocyte engraftment from bone marrow. Exp Hematol (2002) 1.88
Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistry. Am J Surg Pathol (2013) 1.83
Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases. Breast Cancer Res Treat (2007) 1.75
Quantitative quality control in microarray experiments and the application in data filtering, normalization and false positive rate prediction. Bioinformatics (2003) 1.73
Consensus recommendations on estrogen receptor testing in breast cancer by immunohistochemistry. Appl Immunohistochem Mol Morphol (2008) 1.69
Lymphangiogenesis does not occur in breast cancer. Am J Surg Pathol (2005) 1.65
Identification of novel ERK2 substrates through use of an engineered kinase and ATP analogs. J Biol Chem (2003) 1.60
SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype. BMC Cancer (2010) 1.56
Spontaneous mammary intraepithelial lesions in dogs--a model of breast cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.56
The effects of oncotype DX recurrence scores on chemotherapy utilization in a multi-institutional breast cancer cohort. Breast Cancer Res Treat (2011) 1.46
ITF2 is a target of CXCR4 in MDA-MB-231 breast cancer cells and is associated with reduced survival in estrogen receptor-negative breast cancer. Cancer Biol Ther (2010) 1.44
Breast cancer stem cells and intrinsic subtypes: controversies rage on. Curr Stem Cell Res Ther (2009) 1.44
Identification of a molecular signature in human type 1 diabetes mellitus using serum and functional genomics. J Immunol (2008) 1.43
Computer simulations improve university instructional laboratories. Cell Biol Educ (2004) 1.42
Prospective study confirms oxandrolone-associated improvement in height in growth hormone-treated adolescent girls with Turner syndrome. Horm Res Paediatr (2010) 1.42
Superficial temporal artery pseudoaneurysm: diagnosis and preoperative planning with CT angiography. AJNR Am J Neuroradiol (2003) 1.40
Wnt signaling induces epithelial differentiation during cutaneous wound healing. BMC Cell Biol (2006) 1.39
A comparison between SNaPshot, pyrosequencing, and biplex invader SNP genotyping methods: accuracy, cost, and throughput. J Biochem Biophys Methods (2004) 1.38
Genetic analysis of autoimmune type 1 diabetes mellitus in mice. 1991. J Immunol (2014) 1.37
Estrogen promotes tumor progression in a genetically defined mouse model of lung adenocarcinoma. Endocr Relat Cancer (2008) 1.34
FOXA1 as a therapeutic target for breast cancer. Expert Opin Ther Targets (2007) 1.34
The sesquiterpene lactone parthenolide in combination with docetaxel reduces metastasis and improves survival in a xenograft model of breast cancer. Mol Cancer Ther (2005) 1.33
Extrathoracic metastases of thymic origin: a review of 35 cases. Mod Pathol (2011) 1.29
Atypical ductal hyperplasia: interobserver and intraobserver variability. Mod Pathol (2011) 1.28
c-Abl phosphorylates Dok1 to promote filopodia during cell spreading. J Cell Biol (2004) 1.26
Use of a three-color cDNA microarray platform to measure and control support-bound probe for improved data quality and reproducibility. Nucleic Acids Res (2003) 1.25
FOXA1 in breast cancer. Expert Rev Mol Med (2009) 1.23
Effects of HIV protease inhibitor ritonavir on Akt-regulated cell proliferation in breast cancer. Clin Cancer Res (2006) 1.23
AKT alters genome-wide estrogen receptor alpha binding and impacts estrogen signaling in breast cancer. Mol Cell Biol (2008) 1.21
Impaired survival of peripheral T cells, disrupted NK/NKT cell development, and liver failure in mice lacking Gimap5. Blood (2008) 1.19
Apoptosis of CD4+ CD25(high) T cells in type 1 diabetes may be partially mediated by IL-2 deprivation. PLoS One (2009) 1.19
Three color cDNA microarrays: quantitative assessment through the use of fluorescein-labeled probes. Nucleic Acids Res (2003) 1.18
FOXA1 is an independent prognostic marker for ER-positive breast cancer. Breast Cancer Res Treat (2011) 1.17
Phosphoinositol phosphatase SHIP2 promotes cancer development and metastasis coupled with alterations in EGF receptor turnover. Carcinogenesis (2007) 1.16
A phase II study of single agent bortezomib in patients with metastatic breast cancer: a single institution experience. Cancer Invest (2007) 1.16
Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer. Clin Cancer Res (2006) 1.16
At-risk and recent-onset type 1 diabetic subjects have increased apoptosis in the CD4+CD25+ T-cell fraction. PLoS One (2007) 1.15
WHO types A and AB thymomas: not always benign. Mod Pathol (2010) 1.15
NuMA influences higher order chromatin organization in human mammary epithelium. Mol Biol Cell (2006) 1.14
A cancer-associated PCNA expressed in breast cancer has implications as a potential biomarker. Proc Natl Acad Sci U S A (2006) 1.13
Transcriptional characterizations of differences between eutopic and ectopic endometrium. Endocrinology (2005) 1.11
Expression of androgen receptor and prostate-specific antigen in male breast carcinoma. Breast Cancer Res (2003) 1.10
Morphological changes in breast tissue with menstrual cycle. Mod Pathol (2002) 1.08
Predicting response to primary chemotherapy: gene expression profiling of paraffin-embedded core biopsy tissue. Breast Cancer Res Treat (2006) 1.08
Role of AKT isotypes in breast cancer. J Pathol (2013) 1.07
Novel genetic tools reveal Cdk5's major role in Golgi fragmentation in Alzheimer's disease. Mol Biol Cell (2008) 1.07
Invited review: the mitochondrion in osteoarthritis. Mitochondrion (2002) 1.07
The conserved NDR kinase Orb6 controls polarized cell growth by spatial regulation of the small GTPase Cdc42. Curr Biol (2009) 1.07
Investigational drug MLN0128, a novel TORC1/2 inhibitor, demonstrates potent oral antitumor activity in human breast cancer xenograft models. Breast Cancer Res Treat (2012) 1.07
Thymic carcinoma: outcomes after surgical resection. Ann Thorac Surg (2012) 1.07
Meta-analysis of vitamin D receptor polymorphisms and type 1 diabetes: a HuGE review of genetic association studies. Am J Epidemiol (2006) 1.07
Pregnancy after breast cancer: if you wish, ma'am. Breast Cancer Res Treat (2011) 1.07
Persistent upregulation of U6:SNORD44 small RNA ratio in the serum of breast cancer patients. Breast Cancer Res (2011) 1.05
LIMK2 is a crucial regulator and effector of Aurora-A-kinase-mediated malignancy. J Cell Sci (2012) 1.05
Nuclear envelope dispersion triggered by deregulated Cdk5 precedes neuronal death. Mol Biol Cell (2011) 1.05
Towards large-scale histopathological image analysis: hashing-based image retrieval. IEEE Trans Med Imaging (2014) 1.05
Analysis of angiogenesis genes from paraffin-embedded breast tumor and lymph nodes. Breast Cancer Res Treat (2006) 1.04
Computerized classification of intraductal breast lesions using histopathological images. IEEE Trans Biomed Eng (2011) 1.02
The role of NF-kappaB and Smad3 in TGF-beta-mediated Foxp3 expression. Eur J Immunol (2009) 1.02
Dissecting yeast Hog1 MAP kinase pathway using a chemical genetic approach. FEBS Lett (2007) 1.02
Mutant tyrosine kinases with unnatural nucleotide specificity retain the structure and phospho-acceptor specificity of the wild-type enzyme. Chem Biol (2002) 1.02
Interobserver reproducibility in the diagnosis of flat epithelial atypia of the breast. Mod Pathol (2006) 1.02
Deregulated Cdk5 promotes oxidative stress and mitochondrial dysfunction. J Neurochem (2008) 1.01
ANTXR1, a stem cell-enriched functional biomarker, connects collagen signaling to cancer stem-like cells and metastasis in breast cancer. Cancer Res (2013) 1.00
Microsomal prostaglandin E2 synthase-1 in breast cancer: a potential target for therapy. J Pathol (2006) 1.00
Prognostic indicators after surgery for thymoma. Ann Thorac Surg (2010) 1.00
Synthesis and anticancer activity of 5-(3-indolyl)-1,3,4-thiadiazoles. Eur J Med Chem (2010) 0.99
Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study. Breast Cancer Res Treat (2012) 0.99
Investigating the role of islet cytoarchitecture in its oscillation using a new beta-cell cluster model. PLoS One (2007) 0.98
Autoimmune disorders in women with turner syndrome and women with karyotypically normal primary ovarian insufficiency. J Autoimmun (2012) 0.97
Identification of ChChd3 as a novel substrate of the cAMP-dependent protein kinase (PKA) using an analog-sensitive catalytic subunit. J Biol Chem (2007) 0.97